STOCK TITAN

Mannatech Reports Fourth Quarter 2022 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) reported a net sales decline of 13.2% in Q4 2022, totaling $34.3 million compared to $39.5 million in Q4 2021. The operating loss was $2.7 million, contrasting with an operating income of $1.0 million in the prior year. Overall, the company reported a net loss of $7.0 million or $3.78 per diluted share for Q4 2022, down from a profit of $2.6 million or $1.25 per diluted share in Q4 2021. For the full year, net sales decreased by 14.1% and the net loss was $4.5 million, or $2.35 per diluted share. The gross profit margin also decreased to 75.9% due to rising supply chain costs.

Positive
  • Selling and administrative expenses decreased by 6.7% to $27.5 million for 2022.
  • Other operating costs decreased by 7.7% to $20.0 million for the year.
Negative
  • Net sales decreased $22.6 million, or 14.1%, for 2022 compared to 2021.
  • Operating loss was $0.4 million in 2022, a decline from an operating income of $9.0 million in 2021.
  • The number of independent associates and customers dropped from 163,000 to 145,000.

FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of 2022.

Quarter End Results

Fourth quarter net sales for 2022 were $34.3 million, a decrease of $5.2 million, or 13.2%, as compared to $39.5 million in the fourth quarter of 2021. During the fourth quarter, the company's net sales declined 5.1% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during the fourth quarter caused a decrease of $3.2 million in net sales as compared to the fourth quarter of 2021.

The fourth quarter of 2022, tax provision was $3.4 million due to additional taxes assessed due to the settlement of the income tax audit in Korea and the company recording valuation allowance on U.S. deferred tax assets largely driven by changes in expected earnings mix between jurisdictions and the relative impact of these items on decreased earnings.

Fourth quarter operating loss for 2022 was $2.7 million as compared to operating income of $1.0 million for the fourth quarter of 2021.

Fourth quarter net loss was $7.0 million, or $3.78 per diluted share, for the fourth quarter 2022, as compared to net income of $2.6 million, or $1.25 per diluted share, for the fourth quarter 2021.

Gross profit as a percentage of net sales decreased to 69.0% for the three months ended December 31, 2022, as compared to 77.5% for the same period in 2021, due to the rising supply chain costs and volatile changes in the foreign exchange of the Korean Won and the Japanese Yen to US Dollar.

Commissions as a percentage of net sales were 39.2% for the three months ended December 31, 2022, as compared to 38.3% for the same period in the prior year. Incentive costs as a percentage of net sales were 1.6% for the three months ended December 31, 2022, as compared to 1.1% for the same period in 2021.

For the three months ended December 31, 2022, overall selling and administrative expenses decreased by $0.6 million to $7.0 million, as compared to $7.6 million for the same period in 2021. The decrease in selling and administrative expenses consisted primarily of a $0.4 million decrease in marketing costs and a $0.2 million decrease in payroll related costs.

For the three months ended December 31, 2022, other operating costs decreased by $1.0 million to $5.1 million, as compared to $6.1 million for the same period in 2021. The decrease in other operating costs was primarily due to the resolution of the Korea Customs Audit for a $0.4 million lower cost than was expected, (see Note 11 to its Financial Statements filed with its Annual Report for the year ended December 31, 2022), a $0.2 decrease in credit card fees, a $0.2 decrease in research and development costs and a $0.1 million decrease in bad debt expense.

The approximate number of new and continuing independent associate and preferred customer positions held by individuals in Mannatech’s network and associated with purchases of its packs or products as of December 31, 2022 and 2021 were approximately 145,000 and 163,000, respectively. Recruiting decreased 3.6% in the fourth quarter of 2022 as compared to the fourth quarter of 2021. The number of new independent associate and preferred customer positions in the company’s network for the fourth quarter of 2022 was 17,398 as compared to 18,052 in 2021.

Year End Results

Overall net sales decreased $22.6 million, or 14.1%, for 2022, as compared to 2021. During 2022, fluctuations in foreign currency exchange rates had an overall unfavorable impact on its net sales. During 2022, the company's net sales declined 7.6% on a Constant dollar basis (a Non-GAAP financial measure); unfavorable foreign exchange during 2022 caused a decrease of $10.5 million in net sales as compared to 2021.

For the year ended December 31, 2022, the company's tax provision was $4.0 million due to the Korea tax audit settlement and the company recording valuation allowance on U.S. deferred tax assets. During 2021, taxes were a benefit of $1.0 million due to the effect of changes valuation allowances recorded in certain jurisdiction, plus taking the IRC Section 250 deduction and applying tax credits.

Operating loss was $0.4 million in 2022 as compared to operating income of $9.0 million in 2021.

Net loss for 2022 was $4.5 million, or $2.35 per diluted share, as compared to net income of $9.8 million, or $4.71 per diluted share, for 2021.

Gross profit as a percentage of net sales declined to 75.9% for 2022, as compared to 78.6% for 2021 as it was impacted by rising supply chain costs and foreign exchange.

Commissions as a percentage of net sales were 38.2% for the year ending December 31, 2022 and 38.5% for the same period in the prior year.

The costs of incentives, as a percentage of net sales increased to 2.2% for the year ended December 31, 2022, as compared to 1.4% for the same period in 2021.

For the year ended December 31, 2022, overall selling and administrative expenses decreased by 1.9 million, or 6.7%, to $27.5 million, as compared to $29.4 million for the same period in 2021. The decrease in selling and administrative expenses consisted of a $1.1 million decrease in payroll costs, a $0.5 million decrease in marketing costs and a $0.3 million decrease in distribution costs.

For the year ended December 31, 2022, other operating costs decreased by $1.6 million, or 7.7%, to $20.0 million, as compared to $21.6 million for the same period in 2021. For the year ended December 31, 2022, other operating costs, as a percentage of net sales, were 14.6%, as compared to 13.5% for the same period in 2021. The decrease was due to a $0.7 million decrease in credit card fees, the resolution of the Korea Customs Audit (see Note 11 to its Financial Statements filed with its Annual Report for the year ended December 31, 2022) for a $0.4 million lower cost than was expected, a $0.3 million decrease in bad debt expense, and lower professional fees.

As of December 31, 2022, the company's cash and cash equivalents decreased by 43.0%, or $10.4 million, to $13.8 million from $24.2 million as of December 31, 2021. Operating the business was a use of $2.6 million in cash as it invested $3.2 million in inventory. The company invested $1.1 million in computer hardware and software. It used $0.8 million to pay long-term liabilities and finance lease obligations. Finally, shareholder value was returned with $1.5 million for dividends to shareholders and it repurchased $2.0 million in common stock.

Non-GAAP Measures

In addition to results presented in accordance with GAAP, this press release and related tables include certain non-GAAP financial measures, including a presentation of constant dollar measures. The company discloses operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations.

The company believes that these non-GAAP financial measures provide useful information to investors because they are an indicator of the strength and performance of ongoing business operations. The constant currency figures are financial measures used by management to provide investors an additional perspective on trends. Although it believes the non-GAAP financial measures enhance investors’ understanding of their business and performance, these non-GAAP financial measures should not be considered an exclusive alternative to accompanying GAAP financial measures. Please see the accompanying table entitled "Non-GAAP Financial Measures" for a reconciliation of these non-GAAP financial measures.

Safe Harbor statement

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech’s business, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Mannatech.com.

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share information)

 

 

December 31,
2022

 

December 31,
2021

ASSETS

 

 

 

Cash and cash equivalents

$

13,777

 

 

$

24,185

 

Restricted cash

 

944

 

 

 

944

 

Accounts receivable, net of allowance of $973 and $987 in 2022 and 2021, respectively

 

218

 

 

 

90

 

Income tax receivable

 

423

 

 

 

342

 

Inventories, net

 

14,726

 

 

 

12,020

 

Prepaid expenses and other current assets

 

2,389

 

 

 

2,888

 

Deferred commissions

 

2,476

 

 

 

2,369

 

Total current assets

 

34,953

 

 

 

42,838

 

Property and equipment, net

 

3,759

 

 

 

4,239

 

Long-term restricted cash

 

476

 

 

 

503

 

Other assets

 

8,439

 

 

 

9,220

 

Deferred tax assets, net

 

1,501

 

 

 

2,825

 

Total assets

$

49,128

 

 

$

59,625

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

Current portion of finance leases

$

61

 

 

$

68

 

Accounts payable

 

4,361

 

 

 

3,969

 

Accrued expenses

 

7,510

 

 

 

9,224

 

Commissions and incentives payable

 

9,256

 

 

 

9,611

 

Taxes payable

 

3,281

 

 

 

2,154

 

Current notes payable

 

263

 

 

 

205

 

Deferred revenue

 

5,106

 

 

 

4,867

 

Total current liabilities

 

29,838

 

 

 

30,098

 

Finance leases, excluding current portion

 

88

 

 

 

66

 

Other long-term liabilities

 

5,026

 

 

 

5,049

 

Total liabilities

 

34,952

 

 

 

35,213

 

Commitments and contingencies (Note 11)

 

 

 

Shareholders’ equity:

 

 

 

Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding

 

 

 

 

 

Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,742,857 shares issued and 1,858,800 shares outstanding as of December 31, 2022 and 2,742,857 shares issued and 1,940,687 shares outstanding as of December 31, 2021

 

 

 

 

 

Additional paid-in capital

 

33,377

 

 

 

33,277

 

Retained earnings

 

1,686

 

 

 

7,708

 

Accumulated other comprehensive (loss) income

 

(208

)

 

 

2,342

 

Treasury stock, at average cost, 884,057 shares as of December 31, 2022 and 802,170 shares as of December 31, 2021

 

(20,679

)

 

 

(18,915

)

Total shareholders’ equity

 

14,176

 

 

 

24,412

 

Total liabilities and shareholders’ equity

$

49,128

 

 

$

59,625

 

MANNATECH, INCORPORATED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share information)

 

 

For the three months ended December 31,

 

For the years ended December 31,

 

2022

 

2021

 

2022

 

2021

Net sales

$

34,335

 

 

$

39,493

 

 

$

137,208

 

 

$

159,762

 

Cost of sales

 

10,633

 

 

 

8,898

 

 

 

33,060

 

 

 

34,149

 

Gross profit

 

23,702

 

 

 

30,595

 

 

 

104,148

 

 

 

125,613

 

Operating expenses:

 

 

 

 

 

 

 

Commissions and incentives

 

13,996

 

 

 

15,557

 

 

 

55,483

 

 

 

63,784

 

Selling and administrative expenses

 

6,991

 

 

 

7,589

 

 

 

27,470

 

 

 

29,427

 

Depreciation and amortization

 

278

 

 

 

359

 

 

 

1,627

 

 

 

1,719

 

Other operating costs

 

5,087

 

 

 

6,134

 

 

 

19,973

 

 

 

21,634

 

Total operating expenses

 

26,352

 

 

 

29,639

 

 

 

104,553

 

 

 

116,564

 

Income (loss) from operations

 

(2,650

)

 

 

956

 

 

 

(405

)

 

 

9,049

 

Interest income

 

31

 

 

 

22

 

 

 

88

 

 

 

66

 

Other (expense), net

 

(960

)

 

 

(74

)

 

 

(162

)

 

 

(223

)

Income before income taxes

 

(3,579

)

 

 

904

 

 

 

(479

)

 

 

8,892

 

Income tax (provision) benefit

 

(3,440

)

 

 

1,685

 

 

 

(4,011

)

 

 

950

 

Net (loss) income

$

(7,019

)

 

$

2,589

 

 

$

(4,490

)

 

$

9,842

 

(Loss) income per common share:

 

 

 

 

 

 

 

Basic

$

(3.78

)

 

$

1.34

 

 

$

(2.35

)

 

$

4.95

 

Diluted

$

(3.78

)

 

$

1.25

 

 

$

(2.35

)

 

$

4.71

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

1,859

 

 

 

1,929

 

 

 

1,913

 

 

 

1,990

 

Diluted

 

1,859

 

 

 

2,068

 

 

 

1,913

 

 

 

2,088

 

Non-GAAP Financial Measures (Sales, Gross Profit and Income From Operations in Constant Dollars)

To supplement its financial results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), Mannatech discloses operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. It refers to these adjusted financial measures as constant dollar items, which are non-GAAP financial measures. The company believes these measures provide investors an additional perspective on trends. To exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, it calculates current year results and prior year results at a constant exchange rate, which is the prior year’s rate. Currency impact is determined as the difference between actual growth rates and constant currency growth rates.

The table below reconciles fourth quarter 2022 constant dollar sales to GAAP sales.

 

Sales - Q4 2022

 

 

GAAP
Measure:
Total $

 

Non-GAAP
Measure:
Constant $

 

Constant $
Change

 

Americas

$

11.0

 

$

11.0

 

$

 

Asia Pacific

$

20.6

 

$

23.4

 

 

2.8

 

EMEA

$

2.7

 

$

3.1

 

 

0.4

 

Total

$

34.3

 

$

37.5

 

$

3.2

 

The table below reconciles fiscal year 2022 and 2021 constant dollar net sales, gross profit and income from operations to GAAP net sales, gross profit and income from operations.

 

2022

 

2021

 

Constant Dollar Change

 

GAAP
Measure:
Total $

 

Non-GAAP
Measure:
Constant $

 

GAAP
Measure:
Total $

 

Dollar

 

Percent

Net sales

137.2

 

 

147.7

 

$

159.8

 

(12.1

)

 

(7.6

)%

Product

130.2

 

 

140.0

 

 

151.0

 

(11.0

)

 

(7.3

)%

Pack and associate fees

6.2

 

 

6.9

 

 

8.0

 

(1.1

)

 

(13.8

)%

Other

0.8

 

 

0.8

 

 

0.8

 

 

 

%

Gross profit

104.1

 

 

112.4

 

 

125.6

 

(13.2

)

 

(10.5

)%

(Loss) income from operations

(0.4

)

 

1.9

 

 

9.0

 

(7.1

)

 

(78.9

)%

 

Donna Giordano

Manager, Executive Office Administration

972-471-6512

ir@mannatech.com

www.mannatech.com

Source: Mannatech, Incorporated

FAQ

What were Mannatech's fourth quarter earnings results for 2022?

Mannatech reported a net loss of $7.0 million, or $3.78 per diluted share, for Q4 2022.

How did Mannatech's net sales perform in 2022?

Mannatech's net sales decreased by 14.1% in 2022, totaling $134.2 million.

What factors contributed to Mannatech's decline in gross profit in 2022?

Gross profit margin declined due to rising supply chain costs and unfavorable foreign exchange impacts.

What is the current stock symbol for Mannatech?

Mannatech trades under the stock symbol MTEX on NASDAQ.

How did the number of independent associates change for Mannatech in 2022?

The number of independent associates decreased from approximately 163,000 to 145,000 in 2022.

Mannatech Inc.

NASDAQ:MTEX

MTEX Rankings

MTEX Latest News

MTEX Stock Data

21.49M
1.14M
39.43%
20.41%
0.11%
Food Distribution
Medicinal Chemicals & Botanical Products
Link
United States of America
FLOWER MOUND